In this study, we have determined that miR-338-3p inhibits cellular proliferation in GBM cell lines, mirroring the results of a similar analysis done on the role of miR-338-3p in colorectal carcinoma implicating loss of SMO inhibition [44]. Here, SMO is linked to glioblastoma.